TABLE 1

Binding affinity and potency and efficacy for stimulation of GTPγ[35S] binding at hCB1 and hCB2 receptors

CompoundCB1 KiaGTPγ[35S] BindingbCB2 KiaGTPγ[35S] Bindingb
CB1 EC50cCB1 EmaxdCB2 EC50cCB2 Emaxd
CP55,9400.90 (0.76–1.1)14.3 (5.38–38.2)211 (197–225)1.13 (0.91–1.41)3.17 (1.09–9.18)163 (152–174)
11151571313
XLR-1121.2 (15.0–29.8)88.5 (16.3–481)205 (177–233)1.45 (0.94–2.23)39.0 (0.69–2220)135 (116–154)
355355
XLR-11 degradant2.84 (2.14–3.75)90.2 (52.0–157)364 (342–386))1.03 (0.72–1.50)3.32 (0.17–64.4)162 (147–178)
488366
UR-14425.9 (18.5–36.2)93.0 (13.3–651)193 (164–221)2.72 (1.71–4.34)97.4 (1.57–6027)140 (122–158)
355355
UR-144 degradant5.62 (4.13–7.65)140 (82.3–239)381 (358–405)1.81 (1.20–2.72)3.65 (0.72–18.5)169 (156–183)
488366
A-83473518.3 (11.6–29.0)1088 (428–2770)417 (351–483)1.06 (0.77–1.46)3.28 (0.21–50.9)163 (142–183)
344344
A-834735 degradant2.30 (1.75–3.03)88.6 (54.1–145)395 (373–416)0.71 (0.49–1.05)1.50 (0.22–10.4)166 (154–177)
488366
PB-221.09 (0.81–1.47)30.9 (12.8–74.5)415.4 (373–458)5.61 (3.88–8.12)>10 μM (NA)NA
32232
3-carboxyindole metabolite of PB-22>10 μM (NA)>10 μM (NA)NA>10 μM (NA)>10 μM (NA)NA
4838
N-pentylindole>10 μM (NA)Not testedNot tested>10 μM (NA)Not testedNot tested
23
8-OH-quinoline>10 μM (NA)Not testedNot tested>10 μM (NA)Not testedNot tested
33
  • NA, not applicable.

  • a Values represent Ki values (± S.E.M.) in nM for [3H]CP55,940 displacement at specified (hCB1 or hCB2) receptor.

  • b For each measure in all columns, n is shown below the SEM.

  • c Values represent EC50 values (95% confidence interval) in nM for GTPγ[35S] binding at specified (hCB1 or hCB2) receptor.

  • d Values represent percentage GTPγ[35S]-specific binding with basal set at the global percentage shared (∼100%) determined at the specified (hCB1 or hCB2) receptor subtype.